Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
42
ENTA Quote, Financials, Valuation and Earnings
Last price:
$16.45
Seasonality move
:
10.84%
Day range:
$15.84 - $17.05
52-week range:
$4.09 - $17.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.42x
P/B ratio:
7.40x
Volume:
292.1K
Avg. volume:
360K
1-year change:
172.13%
Market cap:
$479.1M
Revenue:
$65.3M
EPS (TTM):
-$3.84
Earnings Data
Next earnings date for ENTA
Feb 09
2026
Most recent earnings per share
-$0.87
Beat by $0.14
(Nov 17/2025)
Consensus Estimate
-$1.01
(Nov 17/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ENTA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/09/2026 | Q4 | $16.1M | -- | -- | -$0.81 | -- |
| 11/17/2025 | Q3 | $16M | $15.1M | -$0.87 | -$1.01 | $0.14 |
| 08/11/2025 | Q2 | $15.6M | $18.3M | -$0.85 | -$0.89 | $0.03 |
| 05/05/2025 | Q1 | $16M | $14.9M | -$1.06 | -$1.14 | $0.08 |
| 02/10/2025 | Q4 | $17.2M | $17M | -$1.05 | -$1.35 | $0.30 |
| 11/25/2024 | Q3 | $17.8M | $14.6M | -$1.36 | -$0.92 | -$0.44 |
| 08/05/2024 | Q2 | $17.2M | $18M | -$1.07 | -$1.41 | $0.34 |
| 05/06/2024 | Q1 | $16.2M | $17.1M | -$1.47 | -$1.40 | -$0.07 |
| 02/07/2024 | Q4 | $21.9M | $18M | -$1.58 | -$1.23 | -$0.36 |
| 11/20/2023 | Q3 | -- | $18.9M | -$1.33 | -- | -- |
| 08/07/2023 | Q2 | -- | $18.9M | -$1.86 | -- | -- |
| 05/08/2023 | Q1 | -- | $17.8M | -$1.79 | -- | -- |
| 02/07/2023 | Q4 | -- | $23.6M | -$1.39 | -- | -- |
| 11/21/2022 | Q3 | -- | $20.3M | -$1.27 | -- | -- |
| 08/08/2022 | Q2 | -- | $19.5M | -$1.53 | -- | -- |
| 05/09/2022 | Q1 | -- | $18.7M | -$1.63 | -- | -- |
| 02/08/2022 | Q4 | -- | $27.6M | -$1.48 | -- | -- |
| 11/22/2021 | Q3 | -- | $23.6M | -$1.22 | -- | -- |
| 08/05/2021 | Q2 | -- | $21.6M | -$1.19 | -- | -- |
| 05/06/2021 | Q1 | -- | $20.1M | -$1.09 | -- | -- |
| 02/08/2021 | Q4 | -- | $31.7M | -$0.41 | -- | -- |
| 11/23/2020 | Q3 | -- | $23.6M | -$1.46 | -- | -- |
| 08/04/2020 | Q2 | -- | $18.7M | -$0.71 | -- | -- |
| 05/06/2020 | Q1 | -- | $27.6M | -$0.30 | -- | -- |
| 02/06/2020 | Q4 | -- | $52.6M | $0.65 | -- | -- |
| 11/21/2019 | Q3 | -- | $51.3M | $0.44 | -- | -- |
| 08/06/2019 | Q2 | -- | $44.4M | $0.33 | -- | -- |
| 05/07/2019 | Q1 | -- | $39.6M | $0.20 | -- | -- |
| 02/06/2019 | Q4 | -- | $69.9M | $1.25 | -- | -- |
| 11/26/2018 | Q3 | -- | $67.2M | $1.30 | -- | -- |
| 08/07/2018 | Q2 | -- | $57.3M | $0.97 | -- | -- |
| 05/08/2018 | Q1 | -- | $44M | $0.61 | -- | -- |
| 02/07/2018 | Q4 | -- | $38.1M | $0.59 | -- | -- |
| 11/20/2017 | Q3 | -- | $75.9M | $1.86 | -- | -- |
| 08/07/2017 | Q2 | -- | $7.5M | -$0.44 | -- | -- |
| 05/08/2017 | Q1 | -- | $9M | -$0.28 | -- | -- |
| 02/08/2017 | Q4 | -- | $10.4M | -$0.26 | -- | -- |
| 11/21/2016 | Q3 | -- | $12.8M | -$0.09 | -- | -- |
| 08/08/2016 | Q2 | -- | $14M | -$0.06 | -- | -- |
| 05/09/2016 | Q1 | -- | $13M | -$0.09 | -- | -- |
| 02/08/2016 | Q4 | -- | $48.4M | $1.36 | -- | -- |
Enanta Pharmaceuticals, Inc. Earnings Questions
-
How Much did Enanta Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Enanta Pharmaceuticals, Inc. reported $15.1M worth of top line sales in its most recent quarter.
-
Did Enanta Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Enanta Pharmaceuticals, Inc. announced earnings per share of -$0.87 which represents a beat of analyst forecast a -$1.01 per share.
-
Is Enanta Pharmaceuticals, Inc. Profitable?
Enanta Pharmaceuticals, Inc. reported $13.8M that represents $0.65 per share over the last quarter.
-
What is the Analyst Consensus for Enanta Pharmaceuticals, Inc. EPS Next Year?
Enanta Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.84 per share to -$3.77 per share next year representing a decrease of -20.11%.
-
When is Enanta Pharmaceuticals, Inc.'s Earnings Date?
Enanta Pharmaceuticals, Inc.'s next earnings date is February 9, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.51% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.27% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 6.84% over the past day.
